Procept BioRobotics Profit Margin

Procept BioRobotics (PRCT) currently reports a profit margin of -32.54% as of June 2026. That compares with -30.6% in the prior-year period — down 6.3% year over year. That is below the Healthcare sector average of 13.45%. Use the charts on this page to explore Procept BioRobotics's profit margin history and peer comparisons.

Procept BioRobotics's profit margin decreased from -30.6% to -32.54% — a 6.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Procept BioRobotics's profit margin of -32.54% is lower than the Healthcare sector average of 13.45%. That is roughly 341.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Procept BioRobotics's current -32.54% should be judged against Healthcare norms (sector average: 13.45%) and against PRCT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -32.54%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.45%. From there, open related valuation or income-statement pages for Procept BioRobotics, and consider following PRCT for alerts when major investors trade the stock.